Related Experiment Video
Updated: Jun 16, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Multimodal Mechanism of Antitumoral Ni(II) Thiosemicarbazones: Deep Mechanistic Understanding of ROS Dynamics,
Lorenzo Verderi1, Silvana Pinelli2, Gloria Cenci1,3
1Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area delle Scienze 17/a, Parma 43124, Italy.
Abstract:
Cancer accounts for nearly one in four deaths (22.8%) due to noncommunicable diseases globally. The urgency for new effective therapies is worsened by resistance. One strategy is to look for multimodal drugs, which undergo different pathways to achieve selective cytotoxicity. Thiosemicarbazones are known to act as antitumoral compounds through multiple modes of action, and Ni-(II) shares some coordination properties with Pt-(II) but is also accessible to redox reactions such as superoxide dismutation catalysis. We found that, in a list of four thiosemicarbazone Ni-(II) complexes all tested on various cancer cell lines, Ni4 displayed IC50 values down to 5 ± 2 μM and over 8-fold selectivity. We investigated how apoptosis was induced, finding at least two different simultaneous mechanisms both involving the Ni-(II) center: first, entrance of the nucleus and coordination of the minor groove of the DNA, modifying its helicity, and second, disruption of the reactive oxygen species (ROS) balance due to the stoichiometric interactions with radical species and catalytic dismutation of hydrogen peroxide, based on the aliphatic N4 substitution that induces a peculiar two-electron exchange reactivity on the Ni-(II) center. Even if we found that Ni2 (cytotoxic but nonselective) is as efficient as literature catalase-like mimics (k cat/K M: 10 ± 2 M-1·s-1), Ni4 treatment hits the upregulation of heme oxygenase (HO-1) and mitochondrial superoxide dismutase (SOD-2). Cyclic voltammetry was used to fully characterize both Ni complexes to investigate the mechanisms of the redox processes associated with electron transfer. Clarifying the cytotoxicity mechanisms, we found that the selectivity is related at least to albumin delivery. Albumin, highly concentrated in the mammalian serum, rapidly seizes the compounds and delivers them selectively to the cancer cells. We found that albumin forms a supramolecular complex with the whole coordination compounds, without sequestering the metal ion, and its affinity is highest for Ni4 (K b: 1.5 ± 0.9 × 106 M-1).
Insights
This study introduces Ni-(II) thiosemicarbazone complexes as novel anticancer agents. The Ni4 complex shows high selectivity and induces cancer cell death through DNA interaction and reactive oxygen species (ROS) modulation, with albumin aiding targeted delivery.
Area of Science:
- Inorganic Chemistry
- Medicinal Chemistry
- Cancer Biology
Background:
- Cancer remains a leading cause of death globally, with drug resistance necessitating novel therapeutic strategies.
- Thiosemicarbazones are a class of compounds known for their multimodal antitumoral activity.
- Nickel(II) complexes offer unique redox properties and coordination chemistry relevant to drug development.
Purpose of the Study:
- To synthesize and evaluate novel Nickel(II) thiosemicarbazone complexes for anticancer activity.
- To elucidate the mechanisms of action, including apoptosis induction and selectivity.
- To investigate the role of albumin in the targeted delivery of these complexes to cancer cells.
Main Methods:
- Synthesis and characterization of four thiosemicarbazone Ni-(II) complexes.
- In vitro cytotoxicity assays on various cancer cell lines to determine IC50 values and selectivity.
- Apoptosis induction studies, including DNA interaction and reactive oxygen species (ROS) balance analysis.
- Cyclic voltammetry to characterize redox properties.
- Albumin binding studies to assess delivery mechanisms.
Main Results:
- The Ni4 complex exhibited significant cytotoxicity (IC50 down to 5 ± 2 μM) with over 8-fold selectivity.
- Ni4 induces apoptosis via dual mechanisms: nuclear DNA minor groove coordination and disruption of ROS balance through interactions with radical species and catalytic hydrogen peroxide dismutation.
- Ni4 treatment upregulated heme oxygenase (HO-1) and mitochondrial superoxide dismutase (SOD-2).
- Albumin selectively binds and delivers Ni4 to cancer cells, with a high binding affinity (Kb: 1.5 ± 0.9 × 10^6 M^-1).
Conclusions:
- Thiosemicarbazone Ni-(II) complexes, particularly Ni4, represent promising multimodal anticancer agents.
- The selectivity of Ni4 is significantly enhanced by albumin-mediated delivery to cancer cells.
- Understanding these mechanisms provides a foundation for developing targeted nickel-based cancer therapies.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
